^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    BluePrint

    Company:
    Agendia
    Type:
    CE Marked
    Related tests:
    almost3years
    MammaPrint and BluePrint tests provide accurate results for thousands of women. Regardless of age.* #SGBCC2023 #breastcancer *MammaPrint® FFPE is CE-marked, and FDA-cleared for 18 years or older. ()
    MammaPrint® • BluePrint
    3years
    Join Agendia at #EBCC13 in Barcelona! Please stop by booth #B3 to discuss the latest data on #MammaPrint and #BluePrint, our comprehensive genomic #breastcancer tests. ()
    MammaPrint® • BluePrint
    over3years
    #CedarsSinaiCancer at #ASCO22. Dr. Alice Chung will be presenting “Identification of transcriptional changes with #MammaPrint and BluePrint in early-stage breast cancer after neoadjuvant #chemotherapy.” @ASCO @CedarsSinaiMed @CSCancerCare @AGiulianoMD #Breastcancer ()
    Clinical
    |
    MammaPrint® • BluePrint
    over4years
    ICYMI - the recorded ⁦@ASBrS⁩ Breakfast Symposia April 30th supported by ⁦@Agendia⁩ featuring ⁦@WhitworthMD⁩ & ⁦@william_audehmd⁩ discussing #MammaPrint + #BluePrint #bcsm https://t.co/bkpCcTs0ky (@KBHock90)
    MammaPrint® • BluePrint
    almost5years
    Join the @Agendia team for an @ASBrS virtual breakfast symposium this Fri 4/30 at 9:00a est @WhitworthMD @william_audehmd A Case-Based Discussion of Integrating MammaPrint and BluePrint into Treatment Planning for Patients with Early Stage Breast Cancer https://t.co/GDPRyRt6AE (@KBHock90)
    Clinical
    |
    MammaPrint® • BluePrint
    5years
    Pat Whitworth, MD @WhitworthMD #NashvilleBreastCenter #SABCS20 #BreastCancer #Cancer #Research NBRST trial: preoperative MammaPrint and BluePrint breast cancer subtype. View full video here: https://t.co/cJYS0NT1T7 (@Agendia)
    Video
    |
    MammaPrint® • BluePrint
    5years
    NBRST trial: preoperative MammaPrint and BluePrint breast cancer subtype Pat Whitworth, MD @WhitworthMD #NashvilleBreastCenter #SABCS20 #BreastCancer #Cancer #Research Link To FULL Video: https://t.co/3TKMv2ss1L (@oncologytube)
    Video
    |
    MammaPrint® • BluePrint
    5years
    lost both mom & sister to mTNBC. Dx in 2016, 6mo after my sister death,I was on a HER2+ treatment plan til my thorough @baptisthealthSF #MiamiCancerInstitute oncologist Sara Garrido used @Agendia #MammaPrint & #BluePrint 💙My #breastcancer was #triplenegative GRATEFUL #iamhere 🙏🏾 (@breasttalkever)
    HER-2 (Human epidermal growth factor receptor 2)
    |
    MammaPrint® • BluePrint
    5years
    @curijoey discusses approach on predicting benefit from pertuzumab, based on abstract from Dr. Krop @DanaFarber - APHINITY and BluePrint molecular subtype. #SABCS20 #bscm (@MVanMeterMD)
    BluePrint
    |
    Perjeta (pertuzumab)